Matsuo, M.; Masuda, M.; Yamauchi, M.; Hashimoto, K.; Kogo, R.; Sato, M.; Masuda, S.; Nakagawa, T.
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers 2024, 16, 2527.
https://doi.org/10.3390/cancers16142527
AMA Style
Matsuo M, Masuda M, Yamauchi M, Hashimoto K, Kogo R, Sato M, Masuda S, Nakagawa T.
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers. 2024; 16(14):2527.
https://doi.org/10.3390/cancers16142527
Chicago/Turabian Style
Matsuo, Mioko, Muneyuki Masuda, Moriyasu Yamauchi, Kazuki Hashimoto, Ryunosuke Kogo, Masanobu Sato, Shogo Masuda, and Takashi Nakagawa.
2024. "Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation" Cancers 16, no. 14: 2527.
https://doi.org/10.3390/cancers16142527
APA Style
Matsuo, M., Masuda, M., Yamauchi, M., Hashimoto, K., Kogo, R., Sato, M., Masuda, S., & Nakagawa, T.
(2024). Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers, 16(14), 2527.
https://doi.org/10.3390/cancers16142527
